Efficacy News and Research

RSS
FDA approves Baxter's GAMMAGARD LIQUID for multifocal motor neuropathy

FDA approves Baxter's GAMMAGARD LIQUID for multifocal motor neuropathy

BV treatment: full enrolment for phase 2 and first phase 3 trial

BV treatment: full enrolment for phase 2 and first phase 3 trial

Study reveals previously unknown function of Thbd-aPC pathway in radiation mitigation

Study reveals previously unknown function of Thbd-aPC pathway in radiation mitigation

GI Dynamics announces clinical data about EndoBarrier Therapy at ASMBS meeting

GI Dynamics announces clinical data about EndoBarrier Therapy at ASMBS meeting

FDA issues CRL to Repligen's RG1068 NDA for treatment of pancreatitis

FDA issues CRL to Repligen's RG1068 NDA for treatment of pancreatitis

Alexza resubmits ADASUVE NDA to U.S. FDA

Alexza resubmits ADASUVE NDA to U.S. FDA

UC3M joins European research project on tuberculosis treatments

UC3M joins European research project on tuberculosis treatments

Aeterna Zentaris announces perifosine Phase 1 trial on neuroblastoma

Aeterna Zentaris announces perifosine Phase 1 trial on neuroblastoma

FDA grants Orphan Drug Designation to Medgenics’ INFRADURE Biopump

FDA grants Orphan Drug Designation to Medgenics’ INFRADURE Biopump

IOF review outlines pathophysiology, diagnosis and management of osteoporosis in young adults

IOF review outlines pathophysiology, diagnosis and management of osteoporosis in young adults

Combination therapy may help defeat pancreatic cancer

Combination therapy may help defeat pancreatic cancer

Furiex initiates MuDelta Phase III studies in IBS-D

Furiex initiates MuDelta Phase III studies in IBS-D

Positive results from Zalicus Z944 Phase 1 SAD clinical study for chronic inflammatory pain

Positive results from Zalicus Z944 Phase 1 SAD clinical study for chronic inflammatory pain

Sustained ventricular arrhythmias in NSTE ACS rare but high-risk

Sustained ventricular arrhythmias in NSTE ACS rare but high-risk

MAQUET's INTERGARD SYNERGY vascular graft receives CE mark

MAQUET's INTERGARD SYNERGY vascular graft receives CE mark

Five abstracts evaluating Abbott's LCIG presented at Parkinson's disease congress

Five abstracts evaluating Abbott's LCIG presented at Parkinson's disease congress

iBio expands iBioModulator portfolio with allowance of patent for anthrax vaccines

iBio expands iBioModulator portfolio with allowance of patent for anthrax vaccines

Pfizer receives FDA Complete Response Letter for tafamidis meglumine NDA

Pfizer receives FDA Complete Response Letter for tafamidis meglumine NDA

Mylan's new online resource seeks to dispel common misconceptions about generic drugs

Mylan's new online resource seeks to dispel common misconceptions about generic drugs

Henry Schein Medical to distribute Alma Lasers' nail fungus treatment

Henry Schein Medical to distribute Alma Lasers' nail fungus treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.